First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study

The efficacy of ceritinib in patients with untreated anaplastic lymphoma kinase (ALK)-rearranged non-small-cell lung cancer (NSCLC) is not known. We assessed the efficacy and safety of ceritinib versus platinum-based chemotherapy in these patients.

Gespeichert in:
Autor*in:

Soria, Jean-Charles [verfasserIn]

Tan, Daniel S W

Chiari, Rita

Wu, Yi-Long

Paz-Ares, Luis

Wolf, Juergen

Geater, Sarayut L

Orlov, Sergey

Cortinovis, Diego

Yu, Chong-Jen

Hochmair, Maximillian

Cortot, Alexis B

Tsai, Chun-Ming

Moro-Sibilot, Denis

Campelo, Rosario G

McCulloch, Tracey

Sen, Paramita

Dugan, Margaret

Pantano, Serafino

Branle, Fabrice

Massacesi, Cristian

de Castro, Gilberto

Format:

E-Artikel

Sprache:

Englisch

Erschienen:

2017

Umfang:

13

Übergeordnetes Werk:

Enthalten in: Effects of shape functions on flexural–torsional buckling of fixed circular arches - Dou, Chao ELSEVIER, 2013, London [u.a.]

Übergeordnetes Werk:

volume:389 ; year:2017 ; number:10072 ; day:4 ; month:03 ; pages:917-929 ; extent:13

Links:

Volltext

DOI / URN:

10.1016/S0140-6736(17)30123-X

Katalog-ID:

ELV030216354

Nicht das Richtige dabei?

Schreiben Sie uns!